A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
To explore the safety and efficacy of IPX056 compared with baclofen tablets for alleviation
of symptoms of spasticity associated with multiple sclerosis (MS).